ATC Group: V08CA06 Gadoversetamide

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of V08CA06 in the ATC hierarchy

Level Code Title
1 V Various
2 V08 Contrast media
3 V08C Magnetic resonance imaging contrast media
4 V08CA Paramagnetic contrast media
5 V08CA06 Gadoversetamide

Active ingredients in V08CA06

Active Ingredient Description
Gadoversetamide

Gadoversetamide is a chelate containing gadolinium – which has paramagnetic properties and is responsible for the contrast enhancement effect in MRI – and the ligand versetamide. Gadoversetamide after intravenous administration, equilibrates rapidly within the extracellular fluid/space and is eliminated primarily by glomerular filtration.

Related product monographs

Title Information Source Document Type  
OPTIMARK Solution for injection European Medicines Agency (EU) MPI, EU: SmPC

Medicines in this ATC group

Austria (AT)

Brazil (BR)

Estonia (EE)

Lithuania (LT)

South Africa (ZA)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.